Zehra Hashim

417 total citations
25 papers, 315 citations indexed

About

Zehra Hashim is a scholar working on Molecular Biology, Clinical Biochemistry and Cancer Research. According to data from OpenAlex, Zehra Hashim has authored 25 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Clinical Biochemistry and 7 papers in Cancer Research. Recurrent topics in Zehra Hashim's work include Connexins and lens biology (5 papers), Paraoxonase enzyme and polymorphisms (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Zehra Hashim is often cited by papers focused on Connexins and lens biology (5 papers), Paraoxonase enzyme and polymorphisms (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Zehra Hashim collaborates with scholars based in Pakistan, United States and Ireland. Zehra Hashim's co-authors include Shamshad Zarina, Uzma Malik, Asmat Salim, Ammara Saleem, Aftab Ahmed, Stephen R. Pennington, Tahir Shamsi, Anna Kwaśnik, Saqib Hussain Ansari and Lisa Staunton and has published in prestigious journals such as SHILAP Revista de lepidopterología, Free Radical Biology and Medicine and Clinica Chimica Acta.

In The Last Decade

Zehra Hashim

22 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zehra Hashim Pakistan 9 152 143 41 39 34 25 315
Kyeojin Kim South Korea 11 174 1.1× 40 0.3× 31 0.8× 20 0.5× 17 0.5× 25 390
Anson Snow United States 7 124 0.8× 33 0.2× 18 0.4× 26 0.7× 37 1.1× 13 248
Nancy Lowe United States 11 217 1.4× 45 0.3× 30 0.7× 48 1.2× 11 0.3× 14 667
Elvira L. Liclican United States 9 134 0.9× 22 0.2× 62 1.5× 48 1.2× 58 1.7× 15 433
Zhenfeng Chen China 10 227 1.5× 31 0.2× 36 0.9× 10 0.3× 10 0.3× 26 438
Awgichew Behaile Teklemariam Ethiopia 4 128 0.8× 45 0.3× 28 0.7× 39 1.0× 6 0.2× 15 295
Sha Wang China 11 241 1.6× 13 0.1× 29 0.7× 52 1.3× 43 1.3× 23 404
Keita Shibata Japan 12 90 0.6× 19 0.1× 51 1.2× 34 0.9× 8 0.2× 30 388
H T Beswick United Kingdom 7 250 1.6× 138 1.0× 134 3.3× 47 1.2× 10 0.3× 8 451

Countries citing papers authored by Zehra Hashim

Since Specialization
Citations

This map shows the geographic impact of Zehra Hashim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zehra Hashim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zehra Hashim more than expected).

Fields of papers citing papers by Zehra Hashim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zehra Hashim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zehra Hashim. The network helps show where Zehra Hashim may publish in the future.

Co-authorship network of co-authors of Zehra Hashim

This figure shows the co-authorship network connecting the top 25 collaborators of Zehra Hashim. A scholar is included among the top collaborators of Zehra Hashim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zehra Hashim. Zehra Hashim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmed, Aftab, et al.. (2025). PPA1, TRIM68 and FBXO46: Potential Therapeutic Targets for Triple Negative Breast Cancer. Current Protein and Peptide Science. 26(5). 365–377.
2.
Salim, Asmat, et al.. (2023). Chemical Hypoxic Preconditioning Improves Survival and Proliferation of Mesenchymal Stem Cells. Applied Biochemistry and Biotechnology. 196(7). 3719–3730. 8 indexed citations
3.
Hashim, Zehra, et al.. (2023). DNA Repair Enzyme XRCC4 30 bp Indel Intron 3 Locus Significant Association with Predisposition of Cataract in Senility. Applied Biochemistry and Biotechnology. 196(1). 99–112. 1 indexed citations
4.
Hashim, Zehra, et al.. (2023). Differential Protein Expression in Response to Varlitinib Treatment in Oral Cancer Cell Line: an In Vitro Therapeutic Approach. Applied Biochemistry and Biotechnology. 196(4). 2110–2121.
5.
Hashim, Zehra, et al.. (2022). Novel Synergistic Combination of Pamidronate and Temozolomide forBreast Cancer Therapeutics. Current Cancer Drug Targets. 23(3). 222–234. 1 indexed citations
6.
Ansari, Saqib Hussain, et al.. (2021). Prenatal diagnosis of maternal serum from mothers carrying β‐thalassemic fetus. Pediatrics International. 64(1). e14999–e14999. 2 indexed citations
7.
Hashim, Zehra, et al.. (2020). Therapeutic effect of hydrogen peroxide via altered expression of glutathione S-transferase and peroxiredoxin-2 in hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international. 19(3). 258–265. 5 indexed citations
8.
Zarina, Shamshad, et al.. (2019). Inhibition of USP2 Induces Apoptosis through Down Regulation of Fatty Acid Synthase and Cyclin D1 in Triple Negative Breast Cancer. Current Proteomics. 17(5). 425–432. 1 indexed citations
9.
Malik, Uzma, Zehra Hashim, Lisa Staunton, et al.. (2019). Identification of Differentially Expressed Proteins from Smokeless Tobacco Addicted Patients Suffering from Oral Squamous Cell Carcinoma. Pathology & Oncology Research. 26(3). 1489–1497. 6 indexed citations
10.
Hashim, Zehra, et al.. (2019). Identification of GIMAP7 and Rabl3 as Putative Biomarkers for Oral Squamous Cell Carcinoma Through Comparative Proteomic Approach. Pathology & Oncology Research. 26(3). 1817–1822. 9 indexed citations
11.
Hashim, Zehra, et al.. (2018). Alendronate and FTI-277 combination as a possible therapeutic approach for hepatocellular carcinoma: An in vitro study. Hepatobiliary & pancreatic diseases international. 17(3). 241–250. 2 indexed citations
12.
Hashim, Zehra, et al.. (2015). Effects of 5′-azacytidine and alendronate on a hepatocellular carcinoma cell line: a proteomics perspective. Molecular and Cellular Biochemistry. 405(1-2). 53–61. 13 indexed citations
14.
Malik, Uzma, et al.. (2014). Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma. Clinica Chimica Acta. 430. 38–42. 32 indexed citations
15.
Hashim, Zehra, et al.. (2014). The Effect of Alendronate on Proteome of Hepatocellular Carcinoma Cell Lines. PubMed. 2014. 1–9. 13 indexed citations
16.
Hashim, Zehra & Shamshad Zarina. (2012). Osmotic stress induced oxidative damage: Possible mechanism of cataract formation in diabetes. Journal of Diabetes and its Complications. 26(4). 275–279. 60 indexed citations
17.
Hashim, Zehra & Shamshad Zarina. (2010). Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract. AGE. 33(3). 377–384. 69 indexed citations
18.
Hashim, Zehra, et al.. (2009). Expression and activity of paraoxonase 1 in human cataractous lens tissue. Free Radical Biology and Medicine. 46(8). 1089–1095. 18 indexed citations
19.
Hashim, Zehra & Shamshad Zarina. (2007). Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract. Clinical Biochemistry. 40(9-10). 705–709. 30 indexed citations
20.
Hashim, Zehra & Shamshad Zarina. (2006). Antioxidant markers in human senile and diabetic cataractous lenses.. PubMed. 16(10). 637–40. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026